Development of transformative therapies for the treatment of worsening and acute decompensated heart failure

Omnes Capital

Invivo Capital Partners

Kurma Partners

V-Bio Ventures

Corteria Pharmaceuticals

CrUX Dataset

Person Schema

CrUX Top 50m

Gravatar Profiles

Chief Medical Officer

Francesca Lawson

Claire Poulard

Ward Capoen

Peter Neubeck

Lluis Pareras

Thierry Laugel

Philip Janiak

Founder & CEO

Marie-Laure Ozoux

Founder & Chief Scientific Officer

Regis Olivier

Therapeutics Companies (Top 10K)

Pharmaceutical Companies With Fewer Than 100 Employees (Top 10K)

Startups with Female Founders (Top 10K)

Europe Companies With Less Than $500M in Revenue (Top 10K)

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.

Jeito Capital

OrbiMed

Series A - Corteria Pharmaceuticals

Seed Round - Corteria Pharmaceuticals

Paris

Ile-de-France

France

Europe

Corteria appoints Mark Pruzanski as chairman

Pharma is focusing on the heart of the problem

Levées de fonds : La French Tech face au défi de la crise du financement

MaddyMoney : 1,78 milliard d'euros levés pendant le mois de ...

Deux cabinets sur le financement de Corteria Pharmaceuticals

Jeito Capital co-leads EUR 65 million (USD 71 M) financing in ...

MindMaze is a competitor of Corteria Neurotechnologies, offering treatments for neurological diseases.

MindMaze

Nexstim is a competitor of Corteria Neurotechnologies, specializing in treatments for neurological disorders.

Nexstim

Johnson & Johnson Services, Inc. offers treatments for multiple sclerosis, Parkinson's disease, and migraine, making it a competitor of Corteria Pharma.

Johnson & Johnson Services, Inc.

Arrakis Therapeutics is a competitor of Corteria Pharmaceuticals, focusing on developing therapeutics for neurological diseases.

Arrakis Therapeutics

MyoKardia is a competitor of Corteria Pharmaceuticals, involved in the development of therapies for cardiovascular and neurological diseases.

MyoKardia

Corteria Pharma is a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological diseases. The company's lead product candidate is targeting Multiple Sclerosis (MS) with a potential best-in-class profile.

Corteria Pharma

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

company_structure

crunchbase_trigger

crunchbase_profile

li_profile

translate_crunchbase_fundingrounds

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	May 16, 2024 8:54 AM	29d3e1b9
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general	Oct 28, 2024 1:50 PM	b7e39818
crunchbase profile	general	Oct 29, 2024 8:24 AM	76ba8f26
li profile	general	May 16, 2024 8:54 AM	27fae51d
translate crunchbase fundingrounds	general
peers	general
news basic	general
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:CORTERIAPHARMA

Corteria Pharma